We are live on ! Find out more
VOYA Investment Management

VOYA Investment Management Portfolio holdings

AUM $96.1B
1-Year Est. Return 40.06%
This Fund
S&P 500
This Quarter Est. Return
+9.78%
1 Year Est. Return
+40.06%
3 Year Est. Return
+122.14%
5 Year Est. Return
+169.19%
10 Year Est. Return
+659.21%
AUM
$48.4B
AUM Growth
+$2.68B
Cap. Flow
-$1.02B
Cap. Flow %
-2.1%
Top 10 Hldgs %
17.92%
Holding
2,721
New
174
Increased
1,803
Reduced
673
Closed
44

Sector Composition

Rank Sector Weight
1 Technology 21.79%
2 Healthcare 13.73%
3 Financials 11.94%
4 Industrials 11.68%
5 Consumer Discretionary 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FET icon
2601
Forum Energy Technologies
FET
$882M
$77K ﹤0.01%
2,293
+654
+40% +$17.7K
PRTK
2602
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$77K ﹤0.01%
19,141
+5,989
+46% +$20.8K
SD icon
2603
SandRidge Energy
SD
$533M
$76K ﹤0.01%
18,004
+6,361
+55% +$26.6K
NBEV
2604
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$76K ﹤0.01%
41,671
+12,817
+44% +$30.3K
DSKE
2605
DELISTED
Daseke, Inc. Common Stock
DSKE
$74K ﹤0.01%
23,352
+8,249
+55% +$24.2K
ZYNE
2606
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$74K ﹤0.01%
+12,238
New +$83.7K
PACD
2607
DELISTED
Pacific Drilling S.A. Common Shares
PACD
$72K ﹤0.01%
17,688
+5,799
+49% +$18.1K
AVTX icon
2608
Avalo Therapeutics
AVTX
$1.06B
$70K ﹤0.01%
5
+1
+25% +$10.5K
AKRX
2609
DELISTED
Akorn Inc
AKRX
$70K ﹤0.01%
46,783
+8,936
+24% +$33.7K
AVXL icon
2610
Anavex Life Sciences
AVXL
$314M
$68K ﹤0.01%
26,163
+7,629
+41% +$20K
ESTE
2611
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$68K ﹤0.01%
+10,816
New +$50.9K
MCRB icon
2612
Seres Therapeutics
MCRB
$50.2M
$67K ﹤0.01%
964
+280
+41% +$20.8K
CELH icon
2613
Celsius Holdings
CELH
$6.89B
$66K ﹤0.01%
+40,908
New +$54.3K
GALT icon
2614
Galectin Therapeutics
GALT
$315M
$66K ﹤0.01%
22,974
+7,797
+51% +$27.1K
XXII
2615
22nd Century Group
XXII
$1.5M
0
ENZ
2616
DELISTED
Enzo Biochem, Inc.
ENZ
$65K ﹤0.01%
24,754
+4,500
+22% +$13.4K
MRNS
2617
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$65K ﹤0.01%
7,470
+2,244
+43% +$12.6K
MDR
2618
DELISTED
McDermott International
MDR
$65K ﹤0.01%
96,335
+23,002
+31% +$29.4K
LCTX icon
2619
Lineage Cell Therapeutics
LCTX
$286M
$64K ﹤0.01%
71,725
+25,491
+55% +$21.2K
MBIO icon
2620
Mustang Bio
MBIO
$4.47M
$64K ﹤0.01%
21
+2
+11% +$4.58K
CASA
2621
DELISTED
Casa Systems, Inc. Common Stock
CASA
$64K ﹤0.01%
15,744
+4,401
+39% +$21K
PRTY
2622
DELISTED
Party City Holdco Inc.
PRTY
$64K ﹤0.01%
27,491
+6,053
+28% +$22.8K
CMRX
2623
DELISTED
Chimerix, Inc.
CMRX
$62K ﹤0.01%
30,741
+8,382
+37% +$15.4K
SENS icon
2624
Senseonics Holdings Inc
SENS
$399M
$61K ﹤0.01%
3,340
+1,160
+53% +$22.9K
ABEO icon
2625
Abeona Therapeutics
ABEO
$425M
$59K ﹤0.01%
718
+199
+38% +$14K

Similar funds

VOYA Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, VOYA Investment Management held 2,721 positions worth $48.4B, up 5.9% from $45.7B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

VOYA Investment Management's Q4 2019 filing shows 174 new, 1,803 increased, 673 reduced and 44 closed positions. Its largest new stake was iShares MSCI EAFE Value ETF: 1,214,827 shares worth $60.7M. The largest sale was Alphabet (Google) Class A, an estimated $315M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • VOYA Investment Management's largest Q4 2019 buy was iShares MSCI EAFE Value ETF: 1,214,827 shares worth $60.7M.
  • VOYA Investment Management added most to Meta Platforms (Facebook) in Q4 2019, an estimated $541M increase.
  • VOYA Investment Management's biggest Q4 2019 reduction was Alphabet (Google) Class A, cutting an estimated $315M.
  • VOYA Investment Management fully exited Celgene Corp in Q4 2019, selling an estimated $39.7M.
  • VOYA Investment Management's ten largest holdings make up 18% of its $48.4B portfolio in Q4 2019.
  • VOYA Investment Management opened 174 new positions and closed 44 in Q4 2019.
  • VOYA Investment Management's portfolio value rose 5.9% quarter-over-quarter to $48.4B.

Based on VOYA Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.